| 1 |
Pharmacokinetically Guided Dose Adjustment of 5-Fluorouracil: A Rational Approach to Improving Therapeutic Outcomes
Muhammad Wasif Saif, Adrienne Choma, Salvatore J. Salamone et al. · JNCI Journal of the National Cancer Institute
|
20 Oct 2009 |
214 |
| 2 |
The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau
Oskar Hansson et al. · Alzheimer s & Dementia
Open access |
31 Mar 2021 |
137 |
| 3 |
Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: An update from the Alzheimer's Association Global Biomarkers Consortium
María C. Carrillo, Kaj Blennow, Holly D Soares et al. · Alzheimer s & Dementia
|
28 Dec 2012 |
134 |
| 4 |
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
Markus Joerger et al. · Annals of Oncology
Open access |
9 Aug 2016 |
90 |
| 5 |
Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapy
William A. Clarke, Étienne Chatelut, Alan Kambiz Fotoohi et al. · European Journal of Cancer
Open access |
29 Sep 2021 |
74 |
| 6 |
Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice
Martin Wilhelm, Lothar Mueller, Michael Craig Miller et al. · Clinical Colorectal Cancer
|
8 May 2016 |
68 |
| 7 |
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
Maria Bjerke et al. · Clinical Chemistry and Laboratory Medicine (CCLM)
|
23 Oct 2015 |
58 |
| 8 |
Body-Surface Area–Based Chemotherapy Dosing: Appropriate in the 21st Century?
Jan Hendrik Beumer, Edward Chu, Salvatore J. Salamone · Journal of Clinical Oncology
Open access |
11 Sep 2012 |
56 |
| 9 |
Evaluation of a Pharmacology-Driven Dosing Algorithm of 3-Weekly Paclitaxel Using Therapeutic Drug Monitoring
Markus Joerger, Stefanie Kraff, Alwin D. R. Huitema et al. · Clinical Pharmacokinetics
|
Sep 2012 |
56 |
| 10 |
Multicenter Evaluation of a Novel Nanoparticle Immunoassay for 5-Fluorouracil on the Olympus AU400 Analyzer
Jan Hendrik Beumer, Michèle Boisdron‐Celle, William A. Clarke et al. · Therapeutic Drug Monitoring
|
Dec 2009 |
53 |
| 11 |
Randomized study of individualized pharmacokinetically‐guided dosing of paclitaxel compared with body‐surface area dosing in Chinese patients with advanced non‐small cell lung cancer
Jie Zhang, Fei Zhou, Huiwei Qi et al. · British Journal of Clinical Pharmacology
Open access |
11 May 2019 |
39 |
| 12 |
Point-of-care measurement of clozapine concentration using a finger-stick blood sample
David M. Taylor, Matthew Atkins, Robert Harland et al. · Journal of Psychopharmacology
|
12 Feb 2021 |
32 |
| 13 |
Excel-Based Tool for Pharmacokinetically Guided Dose Adjustment of Paclitaxel
Stefanie Kraff, Andreas Lindauer, Markus Joerger et al. · Therapeutic Drug Monitoring
|
14 Mar 2015 |
24 |
| 14 |
Validation of a Commercial Assay and Decision Support Tool for Routine Paclitaxel Therapeutic Drug Monitoring (TDM)
Markus Joerger, Stefanie Kraff, Ulrich Jaehde et al. · Therapeutic Drug Monitoring
|
20 Sep 2017 |
21 |
| 15 |
Comparison of Novel Immunoassay With Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) for Therapeutic Drug Monitoring of Clozapine
Tiffany Buckley, Christopher Kitchen, Gopal R. Vyas et al. · Therapeutic Drug Monitoring
Open access |
17 Jun 2020 |
20 |
| 16 |
Highlights from: 5-Fluorouracil Drug Management Pharmacokinetics and Pharmacogenomics Workshop; Orlando, Florida; January 2007
Joseph Bertino, Martin Fleisher, Jan Hendrik Beumer et al. · Clinical Colorectal Cancer
|
Mar 2007 |
17 |
| 17 |
Determination of Busulfan in Human Plasma Using an ELISA Format
Jodi B. Courtney, Rebecca L. Harney, Yunying Li et al. · Therapeutic Drug Monitoring
|
21 Jul 2009 |
17 |
| 18 |
Clinical pharmacokinetics and drug exposure-toxicity correlation study of docetaxel based chemotherapy in Chinese head and neck cancer patients
Yuxiang Ma, Qingguang Lin, Yunpeng Yang et al. · Annals of Translational Medicine
Open access |
Mar 2020 |
16 |
| 19 |
All Optimal Dosing Roads Lead to Therapeutic Drug Monitoring—Why Take the Slow Lane
Jan Hendrik Beumer, Edward Chu, Salvatore J. Salamone · JAMA Oncology
Open access |
20 Oct 2022 |
13 |
| 20 |
The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemia
Rena M. Conti, William V. Padula, Russell V Becker et al. · Journal of Managed Care & Specialty Pharmacy
Open access |
Aug 2021 |
13 |
| 21 |
Development and Evaluation of a Nanoparticle-Based Immunoassay for Determining Paclitaxel Concentrations on Routine Clinical Analyzers
Daniel J. Cline, Hongxia Zhang, Gregory D. Lundell et al. · Therapeutic Drug Monitoring
|
21 Nov 2013 |
12 |
| 22 |
An Automated Nanoparticle-Based Homogeneous Immunoassay for Determining Docetaxel Concentrations in Plasma
Daniel J. Cline, Hongxia Zhang, Gregory D. Lundell et al. · Therapeutic Drug Monitoring
|
21 Nov 2013 |
11 |
| 23 |
An Automated Homogeneous Immunoassay for Quantitating Imatinib Concentrations in Plasma
Jan Hendrik Beumer, Daniel Kozo, Rebecca L. Harney et al. · Therapeutic Drug Monitoring
Open access |
31 Dec 2014 |
10 |
| 24 |
Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer
Yuxiang Ma, Xin Yi Zhao, Xi Chen et al. · Clinical and Translational Medicine
Open access |
Apr 2021 |
9 |
| 25 |
Cost-Effectiveness Of Pharmacokinetic Dosing Of 5-Fluorouracil In Metastatic Colorectal Cancer In The United Kingdom
R Becker, Christopher Hollenbeak, Anna Choma et al. · Value in Health
Open access |
May 2013 |
9 |
| 26 |
Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring
Daniel Kozo, Matt W. Ross, Justin Jarrah et al. · Therapeutic Drug Monitoring
Open access |
11 Apr 2017 |
8 |
| 27 |
Evaluation of a Nanoparticle-Based Busulfan Immunoassay for Rapid Analysis on Routine Clinical Analyzers
Mary Rose Hilaire, Regina V. Gill, Jodi B. Courtney et al. · Therapeutic Drug Monitoring
Open access |
5 Apr 2021 |
5 |
| 28 |
New Immunoassays in Therapeutic Drug Monitoring: Where is the Journey Heading?
Salvatore J. Salamone, Jodi B. Courtney, William A. Clarke · Therapeutic Drug Monitoring
|
3 Oct 2022 |
3 |
| 29 |
Point of care assay for blood aripiprazole concentrations: development, validation and utility
Matthew Atkins, David M. Taylor, Ana Catalán et al. · The British Journal of Psychiatry
Open access |
31 May 2023 |
2 |
| 30 |
P.878 Point of care testing for clozapine
Salvatore J. Salamone, A. Sumanth, Daniel Kozo et al. · European Neuropsychopharmacology
|
Dec 2019 |
2 |
| 31 |
P1–161: Performance testing of a fully automated, Chemiluminescent, beta‐amyloid 42 assay
Irina Baburina, Paul Contestable, George Alexander Green et al. · Alzheimer s & Dementia
|
Jul 2013 |
2 |
| 32 |
A Rapid Nanoparticle Immunoassay to Quantitate Busulfan In Plasma
Salvatore J. Salamone, Caitlyn Benfield, Jodi B. Courtney et al. · Transplantation and Cellular Therapy
Open access |
23 Jan 2009 |
2 |
| 33 |
Evaluation of Busulfan Exposure Calculations Using Novel Busulfan Immunoassay with Standard Mass Spectrometry Based Analytical Method.
Jitesh D. Kawedia, Mary Rose Hilaire, Xiaoqian Liu et al. · Transplantation and Cellular Therapy
Open access |
Feb 2025 |
1 |
| 34 |
The Cost-Effectiveness of Therapeutic Drug Monitoring (TDM) of Generic Imatinib for the Treatment of Chronic Myelogenous Leukemia
Salvatore J. Salamone, R Becker, William V. Padula et al. · Blood
|
7 Dec 2017 |
1 |
| 35 |
424PD Individualization of docetaxel (DTX) treatment in East-Asian advanced non-small cell lung cancer (NSCLC) patients based on pharmacokinetically (PK)-guided dosing strategy: an open-label randomized clinical trial
Yuxiang Ma, Lin Ye, Yanxi Li et al. · Annals of Oncology
Open access |
Dec 2015 |
1 |
| 36 |
P1–137: Stability performance of a fully automated, chemiluminescent, beta‐amyloid 42 assay
Karen Ackles, George Alexander Green, Holly D Soares et al. · Alzheimer s & Dementia
Open access |
Jul 2013 |
1 |
| 37 |
Same sample, different result: Variation in clozapine assay measurement in four UK laboratories
Matthew Atkins, James Fritz, Mary Rose Hilaire et al. · Therapeutic Advances in Psychopharmacology
Open access |
Aug 2026 |
0 |
| 38 |
Evaluation of Busulfan as a Third-Party Immunoassay on a Clinical Chemistry Analyzer
Janet R. Zhou, Andrea To, James S. Fritz et al. · The Journal of Applied Laboratory Medicine
Open access |
9 Feb 2024 |
0 |
| 39 |
Rapid Clozapine Blood Level Determination in a National Health Service Trust
David M. Taylor, Jodi B. Courtney, Mary Rose Hilaire et al. · BJPsych Open
Open access |
Jul 2023 |
0 |
| 40 |
Paclitaxel exposure-toxicity analysis reveals a pharmacokinetic determinant for dose-limiting neutropenia in East-Asian solid tumor patients: results from two prospective, phase II studies
Jinhui Xue, Haipeng He, Zuan Lin et al. · Cancer Chemotherapy and Pharmacology
|
3 Aug 2022 |
0 |
| 41 |
La Salada Characters
Matías Dewey · University of Texas Press eBooks
Book chapterOpen access |
31 Dec 2020 |
0 |
| 42 |
Fully automated immunoassays for measuring beta‐amyloid peptide (1‐42) and total tau in cerebral spinal fluid
Daniel Kozo · Alzheimer s & Dementia
Open access |
Dec 2021 |
0 |
| 43 |
Novel point of care testing device for rapid measurement of clozapine in whole blood
A. Sumanth, Daniel Kozo, Jodi B. Courtney et al. · Clinica Chimica Acta
|
15 May 2019 |
0 |
| 44 |
S115. NOVEL TECHNIQUES FOR THERAPEUTIC DRUG MONITORING FOR CLOZAPINE LEVELS
Gopal R. Vyas, Tiffany Buckley, Christopher Kitchen et al. · Schizophrenia Bulletin
Open access |
Apr 2019 |
0 |
| 45 |
O2‐09‐02: A UNIFIED PRE‐ANALYTICAL PROTOCOL FOR HANDLING OF CSF SAMPLES BEFORE ANALYSES OF AD BIOMARKER LEVELS
Oskar Hansson et al. · Alzheimer s & Dementia
|
Jul 2018 |
0 |
| 46 |
Open-label randomized study of individualized pharmacokinetically (PK)-guided dosing versus body surface area (BSA) dosing of paclitaxel (PTX) in advanced Non-Small Cell Lung Cancer (NSCLC) NCT02058433
Salvatore J. Salamone, J. Zhang, Huiwei Qi et al. · Annals of Oncology
Open access |
Sep 2017 |
0 |
| 47 |
A library of novel monoclonal antibodies for determining levels of 4-hydroxy cyclophosphamide in biological fluids
Salvatore J. Salamone, Jodi B. Courtney, Yunying Li et al. · Cancer Research
|
15 Apr 2006 |
0 |
| 48 |
P1–167: Reproducibility of a fully automated, chemiluminescent, beta‐amyloid 42 assay
Shari Jackson, George Alexander Green, Holly D Soares et al. · Alzheimer s & Dementia
Open access |
Jul 2013 |
0 |
| 49 |
P4‐048: BIOMARKER STABILITY IN CSF: PRE‐ANALYTICAL FACTORS IN A PROSPECTIVE COLLECTION
Daniel Kozo, Salvatore J. Salamone, Irina Baburina et al. · Alzheimer s & Dementia
Open access |
Jul 2014 |
0 |
| 50 |
P4–160: Stability performance of a fully automated, chemiluminescent tau assay for the VITROS® immunodiagnostic systems with cerebrospinal fluid over a 29‐week study
Lisa DiMagno, Shari Jackson, Anne Tweedie et al. · Alzheimer s & Dementia
|
Jul 2013 |
0 |